| For: | Du JY, Zhang CT, Li T, Li YP. Targeting hypoxia and angiogenesis in hepatocellular carcinoma: New insights and therapeutic strategies. World J Hepatol 2024; 16(12): 1371-1376 [PMID: 39744195 DOI: 10.4254/wjh.v16.i12.1371] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v16/i12/1371.htm |
| Number | Citing Articles |
| 1 |
Jayanta Das, Bhupen Barman, Phulen Sarma, Bipul Kumar Das, Rajiv Chetia, Partha Pratim Kalita. Signalling pathways in hepatocellular carcinoma (HCC) metastasis and invasion: Molecular mechanisms and therapeutic implications. Biochemistry and Biophysics Reports 2026; 45: 102403 doi: 10.1016/j.bbrep.2025.102403
|
| 2 |
Diski Saisa, Syifa Mustika, Mochamad Fachrureza, Stevanus Christian Surya, Derren Rampengan, Juan Alessandro Jeremis Maruli Nura Lele, Ammar Nojaid, Michael Owen Hogipranata. Effect of statin use on prognostic outcomes in hepatocellular carcinoma following liver surgery: a systematic review and meta-analysis. European Journal of Gastroenterology & Hepatology 2025; doi: 10.1097/MEG.0000000000003110
|
| 3 |
Mario Romeo, Alessia Silvestrin, Giusy Senese, Fiammetta Di Nardo, Carmine Napolitano, Paolo Vaia, Annachiara Coppola, Pierluigi Federico, Marcello Dallio, Alessandro Federico. From “Traditional” to “Trained” Immunity: Exploring the Novel Frontiers of Immunopathogenesis in the Progression of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). Biomedicines 2025; 13(8): 2004 doi: 10.3390/biomedicines13082004
|
